Clinical trial Recruiting at 2 sites Interventional Ages 18 to 80

3D-printed magnesium alloy prosthesis for repairing bone defects

Official title: The Clinical Study of 3D-printed Magnesium Alloy Prosthesis With Controllable Degradation Rate in the Repair of Periarticular Bone Defects

Run by Peking University Third Hospital · NCT06349629 · Data updated 2026-11-12

This study is testing a new 3D-printed magnesium prosthesis to see if it can help heal bone defects after fractures by supporting new bone growth.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorPeking University Third Hospital
Academic / other
Locations2 sites (Beijing, Haidian and 1 other locations)
StatusRecruiting
StartedJanuary 1, 2023
Main results expectedJanuary 1, 2025
Study endsJanuary 1, 2027
Registry record updatedApril 5, 2024
Trial IDNCT06349629 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 to 70 with traumatic periarticular fractures requiring bone grafting.

Probably not a fit

Patients with pathological fractures, pregnant women, or those with other medical conditions deemed unsuitable for inclusion will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical study focuses on using a 3D-printed magnesium alloy prosthesis designed to repair periarticular bone defects, which are common complications following traumatic fractures. The prosthesis features a personalized design and a porous structure that allows for controlled degradation, promoting new bone regeneration while providing necessary support during the healing process. The study aims to optimize the design of this prosthesis and establish a platform for creating metamaterial pore structures that enhance its effectiveness. Patients will be monitored postoperatively to assess the outcomes of this innovative approach.

Why it matters

Potential benefit: If successful, this approach could significantly improve the healing process and functional recovery for patients with complex bone defects.

How similar studies have gone: While the use of 3D-printed prostheses is gaining traction, this specific approach with magnesium alloy and controlled degradation is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients with traumatic periarticular fractures of extremities with bone defects requiring bone grafting mainly include distal radius fractures, proximal humerus fractures, and tibial plateau fractures.
2. Between the ages of 18 and 70.
3. Sign informed consent, voluntarily participate in the study, and complete postoperative follow-up.
4. There are no obvious surgical contraindications and no contraindications for magnesium alloy prosthesis implantation.

Exclusion Criteria:

* Patients with pathological fracture ② pregnant women ③ doctors evaluated other conditions that were not suitable for inclusion

Where it's running

  • Peking University Third Hospital
    Beijing, Haidian, China
    Recruiting
  • Peking University Third Hospita
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.